UK Oncology plc
By Business Review Editor
Pharma Deals Review: Vol 2002 Issue 29 (Table of Contents)
Published: 2 Oct-2002
DOI: 10.3833/pdr.v2002.i29.994 ISSN: 1756-7874
Section: General
Abstract
Recently, there are rumors of a five-way merger between biotechnology companies - Xenova, Oxford Glycosciences, KS Biomedix, Antisoma and, possibly, British Biotech, to create a leader in anticancer therapy - dubbed UK Oncology plc...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018